# Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol

> **NCT03560375** · PHASE4 · COMPLETED · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Sarcopenia
- Weight Loss

## Interventions

- **BEHAVIORAL:** Circuit resistance training (CRT)
- **BEHAVIORAL:** Vegeterranean diet (V-Med diet)
- **DRUG:** Empagliflozin 10 MG

## Key facts

- **NCT ID:** NCT03560375
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-09
- **Primary completion:** 2021-02-10
- **Final completion:** 2021-02-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560375, "Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03560375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*